ILC Dover Defines the Future of Sterile Manufacturing with the soloPURE™ Flexible Aseptic Isolator

NEWARK,Del.,April 13,2021 -- ILC Dover LP ("ILC Dover" or the "Company"),specializing in the innovative design and production of single-use flexible solutions for global pharmaceutical and biopharmaceutical processing,today introduced the soloPURE™ flexible aseptic isolator,a cost-effective,closed-barrier system for sterile manufacturing. With a fully disposable,single-use chamber and a CAPEX-efficient compact design,soloPURE™ represents the future of sterile manufacturing.

soloPURE™ maximizes efficiency and productivity in the cleanroom,reduces costs while expanding capabilities,and mitigates risk through safe and fully compliant features.

soloPURE™ provides a closed,Grade-A,aseptic environment for fill finish activities requiring positive and negative pressures,giving organizations with facility restraints or expensive closed-barrier systems a better way to handle sterile potent powders,including products previously thought to be "out of reach" in conventional barrier systems. This economical flexible isolator delivers performance equivalent to full hard-walled aseptic isolation systems through bolt-on modules for lyophilization that deliver more capabilities without the added expense. Beyond cost savings,soloPURE™ maximizes productivity with a fully disposable chamber,maximizes cleanroom efficiency through a smaller footprint,enhances operator access with double-sided entry,and mitigates risk with integrity testing throughout its lifecycle.

"ILC Dover is proud to introduce soloPURE™ to the biopharmaceutical market and provide significant time and cost savings to processors through effective single-use solutions," said David Radspinner,President of PharmBio at ILC Dover. "soloPURE™ combines Solo Containment's rich history in single-use isolators and ILC Dover's expertise in flexible powder handling solutions to deliver an efficient,economical,and safe isolator that drastically improves workflow and output for sterile manufacturing."

"soloPURE™ demonstrates both the processing power and sensibility behind single-use solutions,especially for sterile or aseptic processes," said Martyn Ryder,Business and Product Development Manager at ILC Dover. "The single-use,disposable chamber alone allows for rapid campaign changeover,while its double-sided entry increases productivity. While single-use solutions have eluded aseptic processes for decades,soloPURE™ is here to represent the future of sterile manufacturing."

soloPURE™ is available with the capability to sterilize in-place with VHP or operate with a single-use,disposable gamma-irradiated chamber. It can be ordered as a turnkey solution with fast delivery. The launch of soloPURE™ supplements ILC Dover's growing portfolio of single-use solutions for sterile processes and powder transport and hydration,including EZ BioPac®,DoverPac®,and ArmorFlex® Films.

Photo - https://mma.prnasia.com/media2/1485718/ilc_dover_lp_solopure.jpg?p=medium600